CompletedNCT03143855
Lorcaserin and Oxycodone Effects in People With Opioid Use Disorder
About this title
Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
Read the official source — NCT03143855Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- RichmondSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: January 30, 2017
- Recruitment status
- Completed
- Enrollment listed in the registry
- 32
- Sponsor
- Virginia Commonwealth University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03143855
- Official title
Show the full official title
Phase I Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Richmond
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Virginia Commonwealth University, a university.
Did this study involve medication?
Yes. The study involved medication, including Lorcaserin and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
